General Information


DRACP ID  DRACP03804

Peptide Name  

Sequence  XFXLKKK

Sequence Length  7

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C33H54N8O4

Absent amino acids  ACDEGHIMNPQRSTVWY

Common amino acids  K

Mass  95404

Pl  11.1

Basic residues  3

Acidic residues  0

Hydrophobic residues  2

Net charge  3

Boman Index  -875

Hydrophobicity  -72.86

Aliphatic Index  55.71

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32764602

Title  Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of Synthetic peptide antimicrobial peptides

Doi Not available

Year  2020

Literature 2

Pubmed ID 30842436

Title  Characterization, mechanism of action and optimization of activity of a novel peptide-peptoid hybrid against bacterial pathogens involved in canine skin infections

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12736

DRACP is developed by Dr.Zheng's team.